Literature DB >> 18930648

A technological advance comparing epithelial lining fluid from different regions of the lung in smokers.

Toyoki Kodama1, Hiroshi Kanazawa, Yoshihiro Tochino, Shigenori Kyoh, Kazuhisa Asai, Kazuto Hirata.   

Abstract

Cigarette smoking causes inflammatory responses in the airways. However, not all smokers exhibit the development of airflow limitation. This study was designed to determine the implications of small airways inflammation in the development of airflow limitation in smokers by our newly explored method. Twenty-eight smokers (15 smokers without airflow limitation and 13 with airflow limitation) were included in this study. Levels of interleukin-8 (IL-8) and 8-isoprostane were measured in epithelial lining fluid (ELF) from central and peripheral airways separately collected using a bronchoscopic microsampling technique. 8-isoprostane levels in ELF from central or peripheral airways did not significantly differ between the two groups. However, these levels were markedly higher in peripheral than in central airways. Similarly, IL-8 levels in ELF from central airways did not significantly differ between the two groups. In smokers without airflow limitation, IL-8 levels were not higher in peripheral than in central airways. In contrast, in smokers with airflow limitation, IL-8 levels were significantly higher in peripheral airways. Moreover, in smokers with airflow limitation, 8-isoprostane levels in central or peripheral airways were not significantly correlated with FEV(1). However, IL-8 levels in peripheral airways were inversely correlated with FEV(1), though those levels in central airways were not. Thus our technique provides a novel method for ELF sampling from central or peripheral airways separately, and the preliminary evidence that support differences in oxidative stress and neutrophil chemotactic stimulus in these two locations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930648     DOI: 10.1016/j.rmed.2008.09.004

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  3 in total

1.  Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples.

Authors:  Ryan S Thwaites; Hannah C Jarvis; Nehmat Singh; Akhilesh Jha; Andy Pritchard; Hailing Fan; Tanushree Tunstall; Joan Nanan; Simon Nadel; Onn Min Kon; Peter J Openshaw; Trevor T Hansel
Journal:  J Vis Exp       Date:  2018-01-21       Impact factor: 1.355

2.  Advanced glycation endproducts and their receptor in different body compartments in COPD.

Authors:  Susan J M Hoonhorst; Adèle T Lo Tam Loi; Simon D Pouwels; Alen Faiz; Eef D Telenga; Maarten van den Berge; Leo Koenderman; Jan-Willem J Lammers; H Marike Boezen; Antoon J M van Oosterhout; Monique E Lodewijk; Wim Timens; Dirkje S Postma; Nick H T Ten Hacken
Journal:  Respir Res       Date:  2016-04-26

3.  Epithelial Lining Fluid and Plasma Concentrations of Dalbavancin in Healthy Adults after a Single 1,500-Milligram Infusion.

Authors:  Urania Rappo; Michael W Dunne; Sailaja Puttagunta; James S Baldassarre; Shengfang Su; Daksha Desai-Krieger; Megumi Inoue
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.